Return to study ST001376 main page

MB Sample ID: SA100654

Local Sample ID:64_1uM_Coa_added
Subject ID:SU001450
Subject Type:Mammalian Subjects
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:C57BL/6
Age Or Age Range:postnatal day 56
Gender:Male

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001450
Subject Type:Mammalian Subjects
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:C57BL/6
Age Or Age Range:postnatal day 56
Gender:Male

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
64_1uM_Coa_addedSA100654FL014175MorningCollection Time
64_1uM_Coa_addedSA100654FL0141753TCDD treatment(ug/kg)

Collection:

Collection ID:CO001445
Collection Summary:Mice were take down with CO2. Livers were excised and immediatley frozen in liquid nitrogen. Collection time (Morning or Afternoon) denoted in sample factors refers to take-down time. Morning cohort samples were collected from when the light turned on (7 am, ZT0) to ZT3.5. Afternoon cohort samples were collected from ZT5-8.5.
Collection Protocol Comments:Time-point: 28; Time-point Unit: Days;
Sample Type:Liver
Storage Conditions:-80℃

Treatment:

Treatment ID:TR001465
Treatment Summary:oral gavage every 4 days for 28 days. 7 total exposures oral gavage every 4 days for 28 days. 7 total exposures with vehicle or 0.01-30 ug/kg TCDD.
Treatment Protocol Comments:Administration Interval: 4; Administration Interval Unit: DAYS; Dose Unit: ug/kg; Number of Administrations: 7; Chemical Soucre: AccuStandard; Chemical Catalog Number: S-70982; Chemical Purity: -; Vehicle Substance: CHEBI 28119
Treatment Compound:2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
Treatment Route:GAVAGE
Treatment Dose:0.01,0.03,0.1,0.3,1,3,10,30
Treatment Dosevolume:0.1 ml
Treatment Doseduration:28 DAYS;
Treatment Vehicle:Sesame oil

Sample Preparation:

Sampleprep ID:SP001458
Sampleprep Summary:Frozen liver tissue was homegenized in 1000 ul h20:methanol (5:3) mixture5 ml and homegenized, 625 ul chloroform was added,vortexed and spun down at 15,000G. 800 ul of top layer was removed and blown down with nitrogen and reconstituted in 400 l 10mM tetrabutylammonium (TBA)+10mM acetate (pH 5). A further 1:16 dilution was performed for analysis of acetyl-CoA. Coenzyme A (CoA) was measured by standard addition method by diluting with TBA containing CoA standard resulting in 1 uM CoA standard addition. 1 uM CoA standard addition samples are denoted in the subject sample factor section.
Sampleprep Protocol Filename:SP_190815_Acetyl-CoA_modified_Metabolomics_polarextraction.docx
Processing Method:Liquid extraction
Processing Storage Conditions:-80 C

Combined analysis:

Analysis ID AN002296
Analysis type MS
Chromatography type Reversed phase
Chromatography system Acquity H (Waters)
Column Ascentis Express C18 2.1x5cm (Waters)
MS Type ESI
MS instrument type TOF
MS instrument name Waters Xevo G2 XS QTof
Ion Mode NEGATIVE
Units nmol/mg total protein

Chromatography:

Chromatography ID:CH001686
Methods Filename:CH_190829_prj155_28RDDR_LC-MS_expiriment_settings_Xevo_G2-XS_QTof_NEG-mode.txt
Instrument Name:Acquity H (Waters)
Column Name:Ascentis Express C18 2.1x5cm (Waters)
Internal Standard:Acetyl-1,2-13C2 Coenzyme A Sodium Salt (A172214, Toronto Research Chemicals, Toronto, Canada)
Chromatography Type:Reversed phase

MS:

MS ID:MS002139
Analysis ID:AN002296
Instrument Name:Waters Xevo G2 XS QTof
Instrument Type:TOF
MS Type:ESI
MS Comments:Samples were run in MS^e mode. MassLynx V4.2 was used to measure area under the curve. Accurate mass and retention were used for identification of signal for respective metabolites.
Ion Mode:NEGATIVE
Analysis Protocol File:MS_170814_prj140_28RDDR_liver_compound_measurements_QTOF1_NEG.txt
  logo